Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer

OBJECTIVES: Optimal adjuvant treatment for early-stage clear cell and serous endometrial cancer remains unclear. We report outcomes for women with surgically staged International Federation of Gynecology and Obstetrics (FIGO) stage I clear cell, serous, and mixed endometrial cancers following adjuva...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Gynecol Cancer
Hlavní autoři: Jeans, Elizabeth B, Breen, William G, Mullikin, Trey C, Looker, Brittany A, Mariani, Andrea, Keeney, Gary L, Haddock, Michael G, Petersen, Ivy A
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8223628/
https://ncbi.nlm.nih.gov/pubmed/33563642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ijgc-2020-002217
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky